CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

by palligoelme@gmail.com | Jul 22, 2025 | Clinical Trials

​ Conditions: Relapsed or Refractory Plasma Cell Neoplasms Interventions: Other: CAR19BCMA-T cells Sponsors: Chinese PLA General Hospital Not yet recruiting Conditions: Relapsed or Refractory Plasma Cell Neoplasms Interventions: Other: CAR19BCMA-T cells Sponsors:...

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

by palligoelme@gmail.com | Jul 21, 2025 | Clinical Trials

​ Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Drug: BMS-986504; Drug: Gemcitabine; Drug: Nab-paclitaxel; Drug: Placebo Sponsors: Bristol-Myers Squibb Not yet recruiting Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Drug: BMS-986504; Drug:...

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

by palligoelme@gmail.com | Jul 21, 2025 | Clinical Trials

​ Conditions: Small Cell Lung Cancer Interventions: Drug: IBB0979; Drug: topotecan hydrochloride for injection Sponsors: SUNHO（China）BioPharmaceutical CO., Ltd.; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Not yet...

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

by palligoelme@gmail.com | Jul 21, 2025 | Clinical Trials

​ Conditions: Breast Carcinoma Interventions: Other: Non-Interventional Study Sponsors: University of Southern California; National Cancer Institute (NCI) Recruiting Conditions: Breast Carcinoma Interventions: Other: Non-Interventional Study Sponsors: University of...

Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis

by palligoelme@gmail.com | Jul 21, 2025 | Clinical Trials

​ Conditions: Vitamin C; Oral Administration; Erythropoietin; End-Stage Renal Disease; Regular Hemodialysis Interventions: Drug: Normal regimen of treatment of anemia; Drug: Vitamin C; Drug: Vitamin C Sponsors: Ain Shams University Completed Conditions: Vitamin C;...